BridgeMD
New treatment option for Alcohol Use Disorder
Official title Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
ClinicalTrials.gov ID: NCT06959342
What this study is testing
- What it's testing
- The aim of this project is to investigate the potential of transcranial direct current stimulation (tDCS) to reduce cognitive deficits and substance craving in individuals with substance use disorders (SUD), with a focus on alcohol use disorder (AUD). Patients of any gender between the ages of 18 and 65 are examined who are in our inpatient and day clinic settings for a standard detoxification treatment program.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- main diagnosis: alcohol use disorder according to DSM-5
- patients of any gender aged 18 to 65
- normal vision or correctable visual impairment.
- sufficient ability to communicate verbally and in writing
- ability to give fully informed consent after reviewing thorough written information
You likely can't join if
- withdrawal of consent
- severe internal, neurological, or psychiatric comorbidities (e.g., lifetime schizophrenia, bipolar disorder, or other severe mental disorders...
- Exclusion criteria for an EEG/tDCS examination (e.g. metal implants in the head, epilepsy, etc.)
- severe withdrawal symptoms (CIWA-R \> 7)
- alcohol intoxication (breath alcohol concentration \> 0 ‰)
- Pharmacotherapy with psychoactive substances within the last 14 days (exceptions: clomethiazole or benzodiazepines used in withdrawal treatment...
See the full eligibility criteria
- main diagnosis: alcohol use disorder according to DSM-5
- patients of any gender aged 18 to 65
- normal vision or correctable visual impairment.
- sufficient ability to communicate verbally and in writing
- ability to give fully informed consent after reviewing thorough written information
- withdrawal of consent
- severe internal, neurological, or psychiatric comorbidities (e.g., lifetime schizophrenia, bipolar disorder, or other severe mental disorders according to ICD-10 and DSM-5, such as severe depression or PTSD within the...
- Exclusion criteria for an EEG/tDCS examination (e.g. metal implants in the head, epilepsy, etc.)
- severe withdrawal symptoms (CIWA-R \> 7)
- alcohol intoxication (breath alcohol concentration \> 0 ‰)
- Pharmacotherapy with psychoactive substances within the last 14 days (exceptions: clomethiazole or benzodiazepines used in withdrawal treatment, provided they were discontinued at least 3 days prior; antidepressants or...
- drug or alcohol use within the last 7 days
- for women: pregnancy
- suicidal tendencies or danger to others
The study team makes the final eligibility decision.
Where it's taking place
- Mannheim, Germany
- Wiesloch, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mannheim, Germany; Wiesloch, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.